A Single Ascending Dose, Single-Centre Study, to Assess Pharmacokinetics, Safety and Tolerability of a Single Intramuscular Dose of Bedaquiline Long-Acting Injection Formulation in Healthy Participants

Status

Active, not recruiting

Phases

Phase 1

Study type

Interventional

Source

EU CTIS

Registry ID

CTIS2023-508810-41-00

Acronym

TMC207TBC1006

Enrollment

Registered

2024-06-24

Start date

2024-07-01

Completion date

Unknown

Last updated

2025-07-07

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Tuberculosis

None listed

Sex/Gender

All

Age

18 Years to 64 Years

Austria

None listed

Source: EU CTIS · Data processed: Feb 4, 2026